Contact QB3 for event and ticket information.

This event has ended!

View current events hosted by QB3

QED@QB3-UCSF: Emerging Trends in Commercialization of New Therapeutics

Thursday, February 2, 2012 from 4:00 PM to 5:00 PM (PT)

San Francisco, CA

QED@QB3-UCSF: Emerging Trends in Commercialization of New...

Ticket Information

Type End     Quantity
RSVP Ended Free  
Share this!

Event Details

     

Emerging Trends in Commercialization of New Therapeutics

     
 DATE   Thursday, February 2, 2012
TIME   4:00--5:00 pm
PLACE   UCSF Mission Bay, Byers Hall, room 212
SPEAKER   Tony Gottschalk, Gilead Sciences
AGENDA  

Talk with reception to follow in Byers Hall second floor "library"

 
ABOUT THE SPEAKER
     
Tony Gottschalk  

Tony Gottschalk is Director, Marketing Operations at Gilead Sciences where he oversees commercial infrastructure development and customer service operations for Gilead’s specialty products. 

Prior to Gilead, Tony held various sales, marketing and operations positions at Actelion Pharmaceuticals, Cotherix, Quintiles, Abbott Laboratories and Roche Laboratories.  Tony has a B.A. in Molecular, Cellular and Developmental Biology from University of Colorado at Boulder, an MBA from Columbia Business School and an MBA from University of California, Berkeley.